Therapeutic antisense-induced exon skipping in cultured muscle cells from six different DMD patients, Human Molecular Genetics, vol.12, issue.8, pp.907-914, 2003. ,
DOI : 10.1093/hmg/ddg100
Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology, Nature Medicine, vol.306, issue.2, pp.175-177, 2006. ,
DOI : 10.1038/nm1345
Targeted Exon Skipping in Transgenic hDMD Mice: A Model for Direct Preclinical Screening of Human-Specific Antisense Oligonucleotides, Molecular Therapy, vol.10, issue.2, pp.232-240, 2004. ,
DOI : 10.1016/j.ymthe.2004.05.031
MicroRNAs Involved in Molecular Circuitries Relevant for the Duchenne Muscular Dystrophy Pathogenesis Are Controlled by the Dystrophin/nNOS Pathway, Cell Metabolism, vol.12, issue.4, pp.341-351, 2010. ,
DOI : 10.1016/j.cmet.2010.07.008
The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation, Nature Genetics, vol.132, issue.2, pp.228-233, 2006. ,
DOI : 10.1038/ng1725
The regulatory mechanisms that underlie inappropriate transcription of the myogenic determination gene Myf5 in the central nervous system, Developmental Biology, vol.327, issue.1, pp.71-82, 2009. ,
DOI : 10.1016/j.ydbio.2008.11.031
Chimeric snRNA molecules carrying antisense sequences against the splice junctions of exon 51 of the dystrophin pre-mRNA induce exon skipping and restoration of a dystrophin synthesis in ??48-50 DMD cells, Proceedings of the National Academy of Sciences, vol.99, issue.14, pp.9456-9461, 2002. ,
DOI : 10.1073/pnas.142302299
A new vector, based on the PolII promoter for the U1 snRNA gene, for the expression of siRNAs in mammalian cells, Molecular Therapy, vol.10, issue.1, pp.191-199, 2004. ,
DOI : 10.1016/j.ymthe.2004.04.008
Body-wide gene therapy of Duchenne muscular dystrophy in the mdx mouse model, Proceedings of the National Academy of Sciences, vol.103, issue.10, pp.3758-3763, 2006. ,
DOI : 10.1073/pnas.0508917103
Long-Term Benefit of Adeno-Associated Virus/Antisense-Mediated Exon Skipping in Dystrophic Mice, Human Gene Therapy, vol.19, issue.6, pp.601-608, 2008. ,
DOI : 10.1089/hum.2008.012
Modification of splicing in the dystrophin gene in cultured Mdx muscle cells by antisense oligoribonucleotides, Human Molecular Genetics, vol.7, issue.7, pp.1083-1090, 1998. ,
DOI : 10.1093/hmg/7.7.1083
Distinctive patterns of microRNA expression in primary muscular disorders, Proceedings of the National Academy of Sciences, vol.104, issue.43, pp.17016-17021, 2007. ,
DOI : 10.1073/pnas.0708115104
Dystrophin expression in themdx mouse after localised and systemic administration of a morpholino antisense oligonucleotide, The Journal of Gene Medicine, vol.6, issue.2, pp.207-216, 2006. ,
DOI : 10.1002/jgm.838
Stable knockdown of microRNA in vivo by lentiviral vectors, Nature Methods, vol.6, issue.1, pp.63-66, 2009. ,
DOI : 10.1016/j.cell.2005.06.036
Rescue of Dystrophic Muscle Through U7 snRNA-Mediated Exon Skipping, Science, vol.306, issue.5702, pp.1796-1799, 2004. ,
DOI : 10.1126/science.1104297
Common micro-RNA signature in skeletal muscle damage and regeneration induced by Duchenne muscular dystrophy and acute ischemia, The FASEB Journal, vol.23, issue.10, pp.3335-3346, 2009. ,
DOI : 10.1096/fj.08-128579
Exon skipping and Duchenne muscular dystrophy miR-31 targets dystrophin D. Cacchiarelli et al EMBO reports EUROPEAN MOLECULAR BIOLOGY ORGANIZATION scientific report therapy: selection of the most active U1 snRNA-antisense able to induce dystrophin exon 51 skipping, Mol Ther, vol.12, issue.18, pp.1675-1682, 2010. ,
The microRNA miR-181 targets the homeobox protein Hox-A11 during mammalian myoblast differentiation, Nature Cell Biology, vol.123, issue.3, pp.278-284, 2006. ,
DOI : 10.1038/ncb1373
URL : https://hal.archives-ouvertes.fr/inserm-00091598
miRNA in situ hybridization in formaldehyde and EDC???fixed tissues, Nature Methods, vol.13, issue.2, pp.139-141, 2009. ,
DOI : 10.1261/rna.480407
Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy, The Journal of Cell Biology, vol.125, issue.6, pp.1275-1287, 1994. ,
DOI : 10.1083/jcb.125.6.1275
The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation, Journal of Clinical Investigation, vol.119, pp.2366-2378, 2009. ,
DOI : 10.1172/JCI38075DS1
miR-31: A crucial overseer of tumor metastasis and other emerging roles, Cell Cycle, vol.9, issue.11, pp.2124-2129, 2010. ,
DOI : 10.4161/cc.9.11.11843
Local Dystrophin Restoration with Antisense Oligonucleotide PRO051, New England Journal of Medicine, vol.357, issue.26, pp.2677-2686, 2007. ,
DOI : 10.1056/NEJMoa073108
Toward MicroRNA-Based Therapeutics for Heart Disease: The Sense in Antisense, Circulation Research, vol.103, issue.9, pp.919-928, 2008. ,
DOI : 10.1161/CIRCRESAHA.108.183426